As target genes of three branches, DDIT3 (CHOP) and DNAJB9 (IRE1α-XBP1), but not SEL1L (ATF6) were obviously upregulated in glioma cells after treatment of S4, which declared ATF6 was not the main activated branch (Fig. 4C). Here, XBP1 is linked to central nervous system cancer.